High-Throughput Screening Capabilities
Our world-class HTS capabilities include compound and sample management, conventional and next-generation HTS and access to state-of-the-art equipment and readout instruments.
Compound and Sample Management
Conventional and Next Generation High-Throughput Screening (HTS)
Instrumentation – such as PerkinElmer, Inc.’s cell::explorer™ high content screening platform and Opera Phenix™ high content screening system – provides an ideal combination of biologically relevant readouts and throughput; this technology is differentiating how phenotypic screening is being conducted in drug discovery today.